Amanote Research
Register
Sign In
Which Biomarkers Can I Use to Manage Septic Cardiomyopathy
doi 10.2174/9781681080604115010013
Full Text
Open PDF
Abstract
Available in
full text
Date
July 14, 2015
Authors
Unknown
Publisher
BENTHAM SCIENCE PUBLISHERS
Related search
Septic Cardiomyopathy: An Echocardiographic Approach
Septic Cardiomyopathy: A Distinct Histopathological Entity
Choropleth Map – Which Data Type Should I Use?
Abstracts of the ICA
Biomarkers for Pediatric Sepsis and Septic Shock
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Can We Manage B3 Lesions Better?
Breast Cancer Research
Cancer Research
Oncology
Could Biomarkers Direct Therapy for the Septic Patient?
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
"They're Only Preschoolers, I Think I Can Manage Them!" : An Examination of Teacher Efficacy in Early Childhood Educators
Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy
Studies on Hypersensitiveness to Diphtheria Bacilli: I. An "Immediate" Skin Reaction Which Can Be Passively Transferred.
Journal of Experimental Medicine
Medicine
Allergy
Immunology
